All Stories

  1. Abstract 1933: Discovery of first-in-class small molecule CD99 inhibitors for targeted therapy of Ewing sarcoma
  2. Abstract 2446: Ezrin inhibition up-regulates stress response gene expression and blocks osteosarcoma metastasis
  3. Ezrin Inhibition Up-regulates Stress Response Gene Expression
  4. Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non–Small Cell Lung Cancer Cells
  5. Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model
  6. YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model
  7. Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box
  8. Abstract 3269: Ezrin binds to DEAD-box RNA helicase DDX3 and regulates its function and protein level
  9. Abstract 54: Ezrin enhances signaling and nuclear translocation of the epidermal growth factor receptor in non-small cell lung cancer cells
  10. Human papillomavirus type 16 E7 oncoprotein upregulates the retinoic acid receptor-beta expression in cervical cancer cell lines and K14E7 transgenic mice
  11. Ezrin binds to DEAD-box RNA helicase DDX3 and regulates its function and protein level
  12. A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model
  13. Abstract 2949: YK-4-279 is a small molecule inhibitor of ETV1 and inhibits metastasis in a mouse model
  14. Abstract 3979: NSC305787 inhibits specific protein–protein interactions involving ezrin in osteosarcoma cells
  15. Abstract 3987: Evaluation of anti–malarial compounds as inhibitors of ezrin in osteosarcoma cells
  16. Corrigendum to “Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue” [Virology 447 (2013) 155–165]
  17. Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue
  18. In vitro effects of myricetin, morin, apigenin, (+)-taxifolin, (+)-catechin, (−)-epicatechin, naringenin and naringin on cytochrome b5 reduction by purified NADH-cytochrome b5 reductase
  19. The Multidisciplinary Approach to Biochemistry Laboratory Education
  20. Inhibitory activity of apigenin, quercetin, naringenin, (+)-catechin, quercitrin, rutin, and naringin against purified NADH-cytochrome B5 reductase
  21. Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4
  22. Inhibitory effects of dietary flavonoids on purified hepatic NADH-cytochrome b5 reductase: Structure–activity relationships
  23. Species-dependent immunological differences of NADPH-cytochrome P450 reductase between sheep, beef, rat, rabbit, hamster and guinea pig
  24. Evaluation of the Protective Effects of Quercetin, Rutin, Naringenin, Resveratrol and Trolox Against Idarubicin-Induced DNA Damage
  25. Bioreduction of Idarubicin and Formation of ROS Responsible for DNA Cleavage by NADPH-Cytochrome P450 Reductase and its Potential Role in the Antitumor Effect
  26. Erratum: Biochemical characteristics of purified beef liver NADPH-cytochrome P450 reductase
  27. Biochemical characteristics of purified beef liver NADPH-cytochrome P450 reductase